R. E. Y. de Goede

1.8k total citations · 1 hit paper
19 papers, 1.5k citations indexed

About

R. E. Y. de Goede is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, R. E. Y. de Goede has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Virology, 11 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in R. E. Y. de Goede's work include HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (5 papers). R. E. Y. de Goede is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (5 papers). R. E. Y. de Goede collaborates with scholars based in Netherlands, United Kingdom and France. R. E. Y. de Goede's co-authors include Frank Miedema, Matthijs Tersmette, Rob A. Gruters, Hidde L. Ploegh, Han G. Huisman, A. Tulp, Jacques Neefjes, M Tersmette, Fokke G. Terpstra and Maarten Koot and has published in prestigious journals such as Nature, The Lancet and The Journal of Immunology.

In The Last Decade

R. E. Y. de Goede

19 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase

1987 502 citations Rob A. Gruters, Jacques Neefjes et al. Nature profile →

Peers

Countries citing papers authored by R. E. Y. de Goede

Since Specialization

Citations

This map shows the geographic impact of R. E. Y. de Goede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. E. Y. de Goede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. E. Y. de Goede more than expected).

Fields of papers citing papers by R. E. Y. de Goede

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. E. Y. de Goede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. E. Y. de Goede. The network helps show where R. E. Y. de Goede may publish in the future.

Co-authorship network of co-authors of R. E. Y. de Goede

This figure shows the co-authorship network connecting the top 25 collaborators of R. E. Y. de Goede. A scholar is included among the top collaborators of R. E. Y. de Goede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. E. Y. de Goede. R. E. Y. de Goede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Conversion Rate towards a Syncytium‐Inducing (SI) Phenotype during Different Stages of Human Immunodeficiency Virus Type 1 Infection and Prognostic Value of SI Phenotype for Survival after AIDS Diagnosis 1999 ·The Journal of Infectious Diseases ·M. Koot, (unknown), R. E. Y. de Goede, Ireneus P.M. Keet, S. A. Danner, Jan Karel M. Eeftinck Schattenkerk, Peter Reiss, M Tersmette, J. M. A. Lange, Hanneke Schuitemaker	82
2	Conversion rate towards a syncytium inducing (SI) phenotype during different stages of HIV infection and prognostic value of SI phenotype for survival after aids diagnoses 1997 ·Immunology Letters ·M. Koot, R. van Leeuwen, R. E. Y. de Goede, Ireneus P.M. Keet, (unknown), (unknown), (unknown), M Tersmette, Joep M. A. Lange, Hanneke Schuitemaker	1
3	Relation between Changes in Cellular Load, Evolution of Viral Phenotype, and the Clonal Composition of Virus Populations in the Course of Human Immunodeficiency Virus Type 1 Infection 1996 ·The Journal of Infectious Diseases ·M. Koot, Angélique B. van ’t Wout, Neeltje A. Kootstra, R. E. Y. de Goede, M Tersmette, Hanneke Schuitemaker	118
4	Chemical modification of azasugars, inhibitors of N‐glycoprotein‐processing glycosidases and of HIV‐I infection: Review and structure‐activity relationships 1993 ·Recueil des Travaux Chimiques des Pays-Bas ·Leon A. G. M. van den Broek, (unknown), (unknown), C. A. A. VAN BOECKEL, Min Tan, Jan G.M. Bolscher, Hidde L. Ploegh, Folkert J. van Kemenade, R. E. Y. de Goede, Frank Miedema	57
5	Genetic and Functional Analysis of a Set of HIV-1 Envelope Genes Obtained from Biological Clones with Varying Syncytium-Inducing Capacities 1992 ·AIDS Research and Human Retroviruses ·Arno C. Andeweg, M Groenink, P. Leeflang, R. E. Y. de Goede, Albert D. M. E. Osterhaus, Matthijs Tersmette, Marnix L. Bosch	20
6	Differential Tropism of Clinical HIV-1 Isolates for Primary Monocytes and Promonocytic Cell Lines 1992 ·AIDS Research and Human Retroviruses ·Hanneke Schuitemaker, Neeltje A. Kootstra, M Groenink, R. E. Y. de Goede, Frank Miedema, Matthijs Tersmette	26
7	HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay 1992 ·AIDS ·Maarten Koot, (unknown), René Keet, R. E. Y. de Goede, M. W. Dercksen, Fokke G. Terpstra, Roel A. Coutinho, Frank Miedema, Matthijs Tersmette	301
8	Concordance of Human Immunodeficiency Virus Detection by Polymerase Chain Reaction and by Serologic Assays in a Dutch Cohort of Seronegative Homosexual Men 1992 ·The Journal of Infectious Diseases ·Sylvia M. Bruisten, Marco Koppelman, John T. Dekker, Margreet Bakker, R. E. Y. de Goede, Marijke Roos, F. de Wolf, R A Coutinho, Jaap Goudsmit, Han G. Huisman	8
9	Immunological and virological markers in individuals progressing from seroconversion to AIDS 1991 ·AIDS ·Rob A. Gruters, Fokke G. Terpstra, R. E. Y. de Goede, Jan W. Mulder, Frank de Wolf, P T Schellekens, René A. W. van Lier, Matthijs Tersmette, Frank Miedema	70
10	Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy 1990 ·The Lancet ·Charles A. Boucher, J Lange, Jaap Goudsmit, Jan W. Mulder, M Tersmette, R. E. Y. de Goede, Paul Kellam, G. Darby, Brendan Larder	148
11	Human immunodeficiency virus infection studied in CD4-expressing human-murine T-cell hybrids 1989 ·Virology ·M Tersmette, Jacques J. M. van Dongen, Paul R. Clapham, R. E. Y. de Goede, I L Wolvers-Tettero, (unknown), J Huisman, Richard Weiss, Frank Miedema	43
12	Confirmation of HIV seropositivity: Comparison of a novel radioimmunoprecipitation assay to immunoblotting and virus culture 1988 ·Journal of Medical Virology ·M Tersmette, P.N. Lelie, C.L. van der Poel, (unknown), R. E. Y. de Goede, Joep M. A. Lange, Frank Miedema, J Huisman	14
13	Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase breakdown → 1987 ·Nature ·Rob A. Gruters, Jacques Neefjes, Matthijs Tersmette, R. E. Y. de Goede, A. Tulp, Han G. Huisman, Frank Miedema, Hidde L. Ploegh	502
14	Thermal Inactivation of Human Immunodeficiency Virus in Lyophilised Blood Products Evaluated by ID₅₀ Titrations 1986 ·Vox Sanguinis ·(unknown), R. E. Y. de Goede, J Over, (unknown), (unknown), (unknown), Han G. Huisman, Frank Miedema	16
15	Thermal Inactivation of Human Immunodeficiency Virus inLyophilised Blood Products Evaluated by ID(50) Titrations 1986 ·Vox Sanguinis ·(unknown), R. E. Y. de Goede, J Over, (unknown), (unknown), (unknown), Han G. Huisman, Frank Miedema	4
16	Ecotropic and dualtropic mink cell focus-inducing murine leukemia viruses can induce a wide spectrum of H-2 controlled lymphoma types 1984 ·Virology ·Maarten Zijlstra, R. E. Y. de Goede, (unknown), T Radaszkiewicz, Cornelis J.M. Melief	20
17	Naturally occurring leukemia viruses in H-2 congenic C57BL mice III. Characterization of C-type viruses isolated from lymphomas induced by milk transmission of B-ecotropic virus 1983 ·Virology ·Maarten Zijlstra, R. E. Y. de Goede, (unknown), Alfred H. Schinkel, Wim Hesselink, John L. Portis, Cornelis J.M. Melief	18
18	Antibody-Dependent Lymphocytotoxicity: An Analysis of Effector Cell-Target Cell Interactions 1978 ·The Journal of Immunology ·Marinus H. J. van Oers, R. E. Y. de Goede, W.P. Zeijlemaker	7
19	Cytotoxic Activity of Human Lymphocytes: Quantitative Analysis of T Cell and K Cell Cytotoxicity, Revealing Enzyme-Like Kinetics 1977 ·The Journal of Immunology ·(unknown), (unknown), R. E. Y. de Goede, Peter Th.A. Schellekens	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact